Clinical Trial: A Study of Ropeg-Interferon in People With Polycythemia Vera

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07886801) titled 'A Study of Ropeg-Interferon in People With Polycythemia Vera' on Oct. 14.

Brief Summary: The researchers are doing this study to find out whether it is practical (feasible) to stop treatment with ropeg-interferon (ropeg-INF) for some people with polycythemia vera (PV) with a change (mutation) in theJa nus kinase 2 (JAK2) gene, based on how their disease responds to treatment.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Polycythemia Vera (PV) JAK2 Mutation

Intervention: DRUG: Ropeginterferon

Patients will receive treatment with ropeg-IFN at previously established dosing subcutaneous every 2 weeks and escala...